Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by JDavenporton May 11, 2021 11:22am
177 Views
Post# 33173583

RE:RE:question for MBT123

RE:RE:question for MBT123MBT123 is correct. He/she criticises me but we have the same view on this. I refuse to go ugly about it but it's true. We need accomplishment .before we can expect the share price to move. We've always needed that but we've never had it. 

I'm not going to relitigate the performance of past CEOs, not today, at least. I've already made myself clear on that. I have also expressed the opinion that only with the money that the Chiesi and XOMA deals have brought to Bioasis can the company move forward to create the news we so badly need.

This is no time for shareholders to behave badly in such a public manner as we see here. I don't see even the smallest attempts to learn about what Bioasis's plans are, why Bioasis has chosen them or what they're all about. What I see is bad behaviour, on so many levels. But mostly I see weakness, an inability to think clearly when times are difficult.

But in the end, I'm an advocate for the same things that MBT123, beenthere, Aarcor, gfF and others want - resolution, accomplishment, news and a sense of partnership with shareholders who have backed this since 2007 - 14years!

But I will not behave as these people do. I will never so perfectly illustrate weakness as they do. I would never pusposefully try to undercut the efforts of those trying to move this forward, certainly now when for a few months we've had the resources to move forward.

Some people have made this into a hate story where all efforts to improve things are met with the daily expression of that hate. I have news for these. In the end, other than scaring new investment away, which has hurt Bioasis and its shareholders, they will have no effect on the outcome. Bioasis has finally made choices that it can fund and can advance to fruition. Life before June 29, 2020 doesn't exist. 

jd


<< Previous
Bullboard Posts
Next >>